September 29, 2020 09:13 AM EDT

Armed with a PhI cancer drug from Bayer, an Acerta founder breaks cover and writes himself a $60M blank check deal

Ahmed Hamdy has been busy.

This morning Hamdy — one of the key co-founders at Acerta — jumped out of stealth mode with a new biotech that …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Armed with a PhI can­cer drug from Bay­er, an Ac­er­ta founder breaks cov­er and writes him­self a $60M blank check deal